113 related articles for article (PubMed ID: 29211704)
21. Selenium-containing analogs of SAHA induce cytotoxicity in lung cancer cells.
Karelia N; Desai D; Hengst JA; Amin S; Rudrabhatla SV; Yun J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6816-9. PubMed ID: 20855208
[TBL] [Abstract][Full Text] [Related]
22. Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.
Cenik B; Sephton CF; Dewey CM; Xian X; Wei S; Yu K; Niu W; Coppola G; Coughlin SE; Lee SE; Dries DR; Almeida S; Geschwind DH; Gao FB; Miller BL; Farese RV; Posner BA; Yu G; Herz J
J Biol Chem; 2011 May; 286(18):16101-8. PubMed ID: 21454553
[TBL] [Abstract][Full Text] [Related]
23. ELL2 Is Required for the Growth and Survival of AR-Negative Prostate Cancer Cells.
Wang Z; Pascal LE; Chandran UR; Chaparala S; Lv S; Ding H; Qi L; Wang Z
Cancer Manag Res; 2020; 12():4411-4427. PubMed ID: 32606936
[TBL] [Abstract][Full Text] [Related]
24. Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells.
Han H; Li J; Feng X; Zhou H; Guo S; Zhou W
Oncotarget; 2017 Aug; 8(32):53352-53365. PubMed ID: 28881816
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.
Seneviratne JA; Carter DR; Mittra R; Gifford A; Kim PY; Luo JS; Mayoh C; Salib A; Rahmanto AS; Murray J; Cheng NC; Nagy Z; Wang Q; Kleynhans A; Tan O; Sutton SK; Xue C; Chung SA; Zhang Y; Sun C; Zhang L; Haber M; Norris MD; Fletcher JI; Liu T; Dilda PJ; Hogg PJ; Cheung BB; Marshall GM
Int J Cancer; 2023 Apr; 152(7):1399-1413. PubMed ID: 36346110
[TBL] [Abstract][Full Text] [Related]
26. Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.
Lee JI; Nian H; Cooper AJ; Sinha R; Dai J; Bisson WH; Dashwood RH; Pinto JT
Cancer Prev Res (Phila); 2009 Jul; 2(7):683-93. PubMed ID: 19584079
[TBL] [Abstract][Full Text] [Related]
27. Two novel peptides derived from Sinonovacula constricta inhibit the proliferation and induce apoptosis of human prostate cancer cells.
Huang F; Ding G; Yang Z; Yu F
Mol Med Rep; 2017 Nov; 16(5):6697-6707. PubMed ID: 28901516
[TBL] [Abstract][Full Text] [Related]
28. Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3.
Samarghandian S; Afshari JT; Davoodi S
Clinics (Sao Paulo); 2011; 66(6):1073-9. PubMed ID: 21808878
[TBL] [Abstract][Full Text] [Related]
29. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.
Gagliano T; Kerschbamer E; Baccarani U; Minisini M; Di Giorgio E; Dalla E; Weichenberger CX; Cherchi V; Terrosu G; Brancolini C
Biomed Pharmacother; 2024 Apr; 173():116374. PubMed ID: 38447451
[TBL] [Abstract][Full Text] [Related]
30. Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge.
Truong N; Goodis CC; Cottingham AL; Shaw JR; Fletcher S; Pearson RM
ACS Pharmacol Transl Sci; 2022 Nov; 5(11):1128-1141. PubMed ID: 36407956
[TBL] [Abstract][Full Text] [Related]
31. Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells.
Rana Z; Tyndall JDA; Hanif M; Hartinger CG; Rosengren RJ
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33572730
[TBL] [Abstract][Full Text] [Related]
32. Melding a New 3-Dimensional Agarose Colony Assay with the E(max) Model to Determine the Effects of Drug Combinations on Cancer Cells.
Kajiwara Y; Panchabhai S; Liu DD; Kong M; Lee JJ; Levin VA
Technol Cancer Res Treat; 2009 Apr; 8(2):163-76. PubMed ID: 19334798
[TBL] [Abstract][Full Text] [Related]
33. [Study of antitumor effects of human placenta hydrolysate on PC-3, OAW-42, BT-474 cell cultures].
Gromova OA; Filimonova MV; Torshin IY; Frolova DЕ
Ter Arkh; 2024 Apr; 96(3):266-272. PubMed ID: 38713042
[TBL] [Abstract][Full Text] [Related]
34. Development of new nanoniosome carriers for vorinostat: Evaluation of anticancer efficacy in vitro.
Nazari-Vanani R; Kayani Z; Karimian K; Ajdari MR; Heli H
J Pharm Sci; 2024 May; ():. PubMed ID: 38801974
[TBL] [Abstract][Full Text] [Related]
35. PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.
Yin L; Liu Y; Peng Y; Peng Y; Yu X; Gao Y; Yuan B; Zhu Q; Cao T; He L; Gong Z; Sun L; Fan X; Li X
J Exp Clin Cancer Res; 2018 Jul; 37(1):153. PubMed ID: 30012171
[TBL] [Abstract][Full Text] [Related]
36. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods.
Curcio A; Rocca R; Alcaro S; Artese A
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794190
[TBL] [Abstract][Full Text] [Related]
37. Research progress and applications of epigenetic biomarkers in cancer.
Gao J; Shi W; Wang J; Guan C; Dong Q; Sheng J; Zou X; Xu Z; Ge Y; Yang C; Li J; Bao H; Zhong X; Cui Y
Front Pharmacol; 2024; 15():1308309. PubMed ID: 38681199
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents.
Korkmaz IN; Özdemir H
Appl Biochem Biotechnol; 2022 Dec; 194(12):6349-6366. PubMed ID: 35917102
[TBL] [Abstract][Full Text] [Related]
39. From Therapy Resistance to Targeted Therapies in Prostate Cancer.
Moreira-Silva F; Henrique R; Jerónimo C
Front Oncol; 2022; 12():877379. PubMed ID: 35686097
[TBL] [Abstract][Full Text] [Related]
40. Should mutant TP53 be targeted for cancer therapy?
Wang Z; Strasser A; Kelly GL
Cell Death Differ; 2022 May; 29(5):911-920. PubMed ID: 35332311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
